Wagner Wealth Management (South Carolina)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-67
Closed -$5K 294
2022
Q3
$5K Sell
67
-2,326
-97% -$169K ﹤0.01% 506
2022
Q2
$184K Buy
+2,393
New +$182K 0.15% 105
2022
Q1
Sell
-2,464
Closed -$154K 263
2021
Q4
$154K Sell
2,464
-308
-11% -$18.1K 0.12% 139
2021
Q3
$162K Sell
2,772
-283
-9% -$18.6K 0.13% 134
2021
Q2
$204K Buy
3,055
+440
+17% +$28.7K 0.15% 126
2021
Q1
$165K Buy
+2,615
New +$163K 0.13% 132
2018
Q3
$87K Hold
1,400
0.06% 203
2018
Q2
$77K Buy
1,400
+347
+33% +$18.7K 0.06% 198
2018
Q1
$67K Buy
1,053
+370
+54% +$23.8K 0.05% 197
2017
Q4
$43K Buy
+683
New +$42.7K 0.03% 226

Other funds holding BMY

Wagner Wealth Management (South Carolina)'s BMY Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 67 shares — an estimated $5K sold.

Wagner Wealth Management (South Carolina) first reported a position in BMY in Q4 2017 and held it in 10 quarters. The position peaked at $204K in Q2 2021. 2,601 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Wagner Wealth Management (South Carolina) reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 67 Bristol-Myers Squibb shares in Q4 2022, an estimated $5K.
  • Wagner Wealth Management (South Carolina) first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 10 quarters.
  • Wagner Wealth Management (South Carolina)'s Bristol-Myers Squibb position peaked at $204K in Q2 2021.
  • 2,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.